Secures and Consolidates Unrestricted Rights for Simoa Technology in Diagnostics Market
Press Releases
September 05, 2018
Company also attending Citi’s 13th Annual Biotech Conference
August 08, 2018
66% revenue growth
Integration of Aushon in process
August 06, 2018
Neurofilament light chain (NfL) proves to be a transformative biomarker for understanding wide range of neurological conditions and advancing clinical trials
July 30, 2018
Lexington, Mass.
July 26, 2018
Quanterix’ Ultra-Sensitive Technology Creates Breakthroughs in Brain Health of Military and Veterans
July 23, 2018
New research advances the diagnosis of concussions and PTSD for those in the line of duty
June 27, 2018
Kevin Hrusovsky Will Address Early Diagnosis Through Predictive Biomarkers at Executive Summit on July 11
June 15, 2018
Lexington, Mass.
May 09, 2018
Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the first quarter 2018.